WAVE Life Sciences (WVE)
(Delayed Data from NSDQ)
$8.63 USD
+0.53 (6.54%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $8.62 -0.01 (-0.12%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, WAVE Life Sciences Ltd. has a market cap of $1.29B, which represents its share price of $8.10 multiplied by its outstanding shares number of 159.14M. As a small-cap company, WVE's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
WVE 8.63 +0.53(6.54%)
Will WVE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for WVE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WVE
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
WVE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates
Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates
Myriad Genetics (MYGN) Reports Q1 Loss, Misses Revenue Estimates
Other News for WVE
WVE: Analyst Lowers Price Target While Maintaining Overweight Rating | WVE Stock News
WAVE Life Sciences Ltd (WVE) Q2 2025 Earnings Call Highlights: Progress in RNA Editing Amid ...
Q2 2025 WAVE Life Sciences Ltd Earnings Call Transcript
Decoding WAVE Life Sciences Ltd (WVE): A Strategic SWOT Insight
Wave Life Sciences (WVE) Advances RNA Editing Programs Amid Financial Challenges